The medical device industry needs to learn from the failures and the achievements of other industries to bring its supply chains up to date, writes Lora Cecere, founder of Supply Chain Insights. Cecere recommends taking five steps to improve supply chains, such as using customer scorecards and capitalizing on channel data. “We need for supply chain leadership to step up to the plate,” she adds.
Starts tomorrow March 12th. 8 sessions packed on useful information on DSCSA, SAP OER / AII / GBT / EM, Implementation experience… Focused specifically on the Pharma industry and a second track on the SAP solutions provided for Serialized and Batch Track and Trace.
What does the Drug Quality and Security Act of 2013 (DQSA), formerly referred to as HR 3204, mean to you?
On November 27, 2013 H.R. 3204 was signed into US Federal law as the Drug Quality and Security Act of 2013 (DQSA). Among other things, the new law will impact the way prescription drug trades are documented in the United States and preempt state laws for drug traceability, including California’s e-pedigree law. This one hour session outlines the requirements of the DQSA, Title II, referred to as the Drug Supply Chain Security Act (DSCSA).
Congress enacted the Drug Quality and Security Act of 2013 (DQSA), formerly referred to as HR 3204, in November 2013 and it starts to take effect in a significant way in January 2015. You should be planning to attend the 1st annual Serialized Track-and-Trace Seminar on 12th March, 2014. This is a virtual event that allows you to attend the sessions from the comfort of your own home or office, yet you still have access to all the content and experts that you would expect from a live event. It’s a truly unique and valuable opportunity for those focused on these latest changes in legislation for the Pharma industry. Continue reading →